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Oxygen homeostasis is an essential regulation system for cell energy production and survival. The oxygen-sensitive
subunit 
 
 
 
 of the hypoxia inducible factor-1 (HIF-1) complex is a key protein of this system. In this work, we analyzed
mouse and rat HIF-1
 
 
 
 protein and mRNA expression in parallel to energetic metabolism variations within skeletal
muscle. Two physiological situations were studied using HIF-1
 
 
 
–speciﬁc Western blotting and semiquantitative
RT-PCR. First, we compared HIF-1
 
 
 
 expression between the predominantly oxidative soleus muscle and three
predominantly glycolytic muscles. Second, HIF-1
 
 
 
 expression was assessed in an energy metabolism switch model
that was based on muscle disuse. These two in vivo situations were compared with the in vitro HIF-1
 
 
 
 induction by
CoCl
 
2
 
 treatment on C
 
2
 
C
 
12
 
 mouse muscle cells. HIF-1
 
 
 
 mRNA and protein levels were found to be constitutively
higher in the more glycolytic muscles compared with the more oxidative muscles. Our results gave rise to the
hypothesis that the oxygen homeostasis regulation system depends on the ﬁber type.
 
INTRODUCTION
 
Eukaryotic cells sense oxygen and adapt to hypoxia by
regulating a certain number of genes. This was shown
many years ago for various mammalian cell types, in-
cluding C
 
2
 
C
 
12
 
 myoblasts (Webster, 1987). The HIF-1
(hypoxia inducible factor-1) transcription factor is a
key element of this pleiotropic response. Wang and
Semenza (1993) observed that HIF-1 DNA binding
activity is speciﬁcally present under low oxygen condi-
tions for different cell lines, including muscle cells.
Activated HIF-1 comprises two subunits, i.e., HIF-1
 
 
 
and HIF-1
 
 
 
. HIF-1
 
 
 
 plays a central role as it is sub-
jected to drastic O
 
2
 
-dependent proteasomal control.
At normoxia, HIF-1
 
 
 
 and HIF-1
 
 
 
 are constitutively
expressed but HIF-1
 
 
 
 is mainly ubiquitinated and de-
graded by the proteasome (Jaakkola et al., 2001). In
severe hypoxia, the HIF-1
 
 
 
 protein level increases by
relaxing its degradation, and HIF-1
 
 
 
 can form an active
complex with HIF-1
 
 
 
. Activated HIF-1 induces the ex-
pression of genes involved, for example, in angiogenesis,
erythropoiesis, glucose uptake, and energy metabolism
(Semenza, 2000a; Wenger, 2000). HIF-1
 
 
 
 can also be
regulated at the mRNA level, but this is less docu-
mented than the regulation at protein level (Semenza,
2000b). Induction of HIF-1
 
 
 
 mRNA following acute
hypoxia was reported in vivo in rodent ferret brain,
lung, or kidney (Wiener et al., 1996; Yu et al., 1998)
and in cultured cell lines (Wang et al., 1995). Similarly,
chronic ischemia was found to be associated with
HIF-1
 
 
 
 mRNA up-regulation in rat brain (Bergeron
et al., 1999). Considering the striated muscle tissue,
treatment with phorbol ester was shown to increase rat
cardiomyocyte HIF-1
 
 
 
 mRNA in tissue culture (Ladoux
and Frelin, 1997); increase in the steady-state levels of
cardiac HIF-1
 
 
 
 mRNA has also been shown to be part
of the early response to myocardial ischemia or infarc-
tion in humans (Lee et al., 2000) and to occur under
high glucose concentrations in rats (Marfella et al.,
2002). Several studies have reported an increase of
skeletal muscle HIF-1
 
 
 
 mRNA in chronic hypoxia con-
ditions such as adaptation to altitude (Hoppeler and
Vogt, 2001a,b). Finally, a recent study involving a global
analysis by cDNA arrays of transcription proﬁles in
chronic critical and acute-on-chronic human skeletal
muscle ischemia conditions demonstrated up-regulation
of genes involved in the HIF-1 system, including HIF-1
itself (Tuomisto et al., 2004).
HIF-1 studies in skeletal muscle are difﬁcult due to
the presence of a number of energy metabolism systems
that include different O
 
2
 
 supplies and homeostasis,
with different proportions of oxidative, glycolytic, and
intermediate ﬁbers. Indeed, it has been shown that
skeletal muscle presents a continuum of mechanical
and metabolic properties from the slow contractile
speed type I ﬁbers, which have a low fatigability, to
the fast contractile speed type IIb ﬁbers, which have a
high fatigability. Type I ﬁber energy is mainly sustained
by an oxidative metabolism, while type IIb energy is
mainly generated by a glycolytic metabolism (Booth
and Baldwin, 1996). Moreover, this metabolic/mechani-
cal status is not ﬁxed, but adapts to environmental changes
such as chronic activity modiﬁcations. For instance,
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slow-twitch muscles modify their phenotype from a pre-
dominantly oxidative slow- to a glycolytic fast-type me-
tabolism under different physiological or experimental
conditions of muscle atrophy induced by restriction of
muscle activity (Diffee et al., 1991; Ohira et al., 1992;
Cros et al., 2001).
In this study, we investigated HIF-1
 
 
 
 mRNA and pro-
tein expression in relation with muscular energy me-
tabolism types. Our observations strongly suggest that
HIF-1
 
 
 
 expression is ﬁber type dependent.
 
MATERIALS AND METHODS
 
Animals and Tissues
 
All procedures were approved by the local Centre National de la
Recherche Scientiﬁque ethics committee. Entire soleus and tibia-
lis anterior, lateral gastrocnemius, and middle region of quadri-
ceps muscles were quickly excised from anesthetized (intraperi-
toneal injection of pentobarbital, 1 
 
 
 
L/g of body mass) 10 wk-
old Ico: OF1 (Caw) mice (Charles Rivers Laboratories), and then
cleaned and immediately frozen in liquid nitrogen for RNA and
protein immunoblotting analysis. Rat gastrocnemius and soleus
muscles atrophied by 2 wk of hindlimb suspension and control
muscles were derived from a previous study (Cros et al., 2001).
 
Cell Culture
 
C
 
2
 
C
 
12
 
 mouse skeletal muscle cells were obtained from the Ameri-
can Type Culture Collection (ATCC no. CRL-1772), and grown
in Dulbecco’s modiﬁed Eagle’s medium with 4.5 g/liter glucose
and 10% FCS. Myotube C
 
2
 
C
 
12
 
 differentiation was induced by
withdrawing FCS and adding 10 
 
 
 
g/ml insulin, 5 
 
 
 
g/ml transfer-
rin, and 2% horse serum. Cells were stressed by adding 200 
 
 
 
M
CoCl
 
2
 
 to the culture medium for indicated lengths of time.
 
RNA Analysis
 
Total RNA was isolated using Tri-reagent (Euromedex) accord-
ing to manufacturer’s instructions, from nine-rat or -mouse pool
frozen muscles or from three fresh C
 
2
 
C
 
12
 
-culture dishes, to elimi-
nate individual variations. Semi-quantitative RT-PCR (reverse
transcriptase using Invitrogen M-MMLV reverse transcriptase
and polymerase chain reaction using CLONTECH Laboratories,
Inc. Advantage Klen Taq polymerase) cDNA ampliﬁcation and
quantiﬁcation were performed as described previously (Pisani et
al., 2004). In brief, ethidium bromide intensity of agarose elec-
trophoretic bands was quantiﬁed with PCBas software in the lin-
ear ampliﬁcation range determined from 15 to 35 PCR cycle am-
pliﬁcations. HIF-1
 
 
 
 cDNA fragments were ampliﬁed as described
by Marfella et al. (2002), and 18S rRNA fragments were ampli-
ﬁed as described by Pisani et al. (2004).
 
Protein Analysis
 
For immunoblotting analysis, nuclear proteins were extracted
from fresh excised skeletal muscle (Ulukan et al., 2001). In brief,
muscles were disrupted with a Polytron homogenizer in 5 ml of
ice-cold buffer A (100 mM NaCl, 20 mM KCl, 0.5 mM Na
 
2
 
PO
 
4
 
, 20
mM Tris-HCl, pH 7.5), and then centrifuged at 350 
 
g
 
 for 10 min.
Pellets were resuspended in 2 ml of ice-cold buffer B (100 mM
NaCl, 50 mM KCl, 0.1 mM EDTA, 20 mM Tris-HCl, pH 7.5, 10%
glycerol, 0.2% NP-40, 0.1% Triton X-100), incubated 10 min on
ice and centrifuged at 350 
 
g
 
 for 10 min. Nuclei from pellets were
lysed with 200 
 
 
 
l of ice-cold buffer B supplemented with 1% SDS
and a protease inhibitor cocktail (Sigma-Aldrich). Total soluble
proteins were prepared from fresh cell cultures by immediate
extraction in ice-cold lysis buffer (50 mM Hepes, pH 7.4, 150
mM NaCl, 100 mM NaF, 10 mM EDTA, 10 mM Na
 
4
 
P
 
2
 
O
 
7
 
, 2
mM Na
 
3
 
VO
 
4
 
, 1% Triton X-100, supplemented with protease in-
hibitors cocktail) (Yeow et al., 2002). All protein concentrations
were determined with the Bio-Rad Laboratories protein assay re-
agents. Equal amounts of proteins were separated by SDS-PAGE
on 6% acrylamide gels. Proteins were transferred to Hybond-C
extra membranes (Amersham Biosciences) and stained with pon-
ceau red to check whether the transfers were uniform. Blots were
then incubated for 4 h at room temperature in TBS with 0.1%
Tween-20 and 5% nonfat powdered milk. Membranes were
probed overnight at 4
 
 
 
C with anti-HIF-1
 
 
 
 polyclonal antibody
(provided by C. Brahimi-Horn and J. Pouysségur, CNRS UMR
6543, Nice, France), at 1:2,000 dilution in TBS, 0.1% Tween-20,
1% nonfat powdered milk, and then for 1 h at room temperature
with an HRP-conjugated swine anti-rabbit IgG (Dako) used at
1:2,000 dilution in TBS, 0.1% Tween-20, and 5% nonfat powdered
milk. After each incubation, membranes were washed three
Figure 1. Comparison of
HIF-1  expression in slow
(soleus) versus fast (gastroc-
nemius, tibialis anterior,
quadriceps) mouse skeletal
muscles. (A) Protein analysis
by Western blotting on skele-
tal muscle nuclear protein
extracts. HIF-1  was detected
as a speciﬁc 120-kD band, and
an 80-kD nonspeciﬁc band
stained with amido black is
shown as an even-lane loading
control. Lanes were evenly
loaded with 25  g of proteins.
(B) RNA analysis performed
by semiquantitative RT-PCR
on skeletal muscle RNAs.
Partial HIF-1  mRNAs were
ampliﬁed and quantiﬁed and 18S rRNAs were used for normalization. The band intensity was measured, in linear PCR ampliﬁcation
range, and the results are expressed in arbitrary units after normalization. Histograms represent mean   SEM of three independent
experiments from two independent RNA or protein preparations. *, signiﬁcantly different from soleus muscle (A, P   0.001; B, P   0.03). 
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times in TBS, 0.1% Tween-20, for 10 min per wash. Proteins were
then revealed using the Amersham Biosciences ECL system.
 
Statistical Analysis
 
t
 
 tests were performed using SigmaStat software to compare dif-
ferences between two groups of values. Statistical differences
were noted * (P 
 
  
 
0.05).
 
RESULTS
 
Difference in HIF-1
 
 
 
 Expression between Oxidative- and 
Glycolytic-energy Metabolism Muscle Fibers
 
We compared HIF-1
 
 
 
 expression between a predomi-
nantly oxidative muscle (soleus) and three predomi-
nantly glycolytic muscles (gastrocnemius, tibialis ante-
rior, and quadriceps). The analysis was performed on
nuclear protein extracts from mouse muscles, which
were immediately snap frozen in liquid nitrogen after
excision to avoid any modiﬁcations induced by tissue
hypoxia. With the same goal, the ﬁrst step of protein
or RNA preparations were carefully performed di-
rectly using frozen tissues. First, we investigated the
HIF-1
 
 
 
 protein level by Western blotting (Fig. 1 A). A
speciﬁc 120-kD signal was detected with a monoclo-
nal anti–HIF-1
 
 
 
 antibody on nuclear protein extracts.
HIF-1
 
 
 
 quantities were reproducibly found to be 8- to
10-fold higher in glycolytic muscles than in the oxida-
tive soleus muscle. Despite the care taken in tissue
storage and protein preparation for all muscles, we
could not rule out that the drastic difference noted
between glycolytic muscles and the oxidative muscle
was caused by very short-term hypoxic conditions for
glycolytic muscle sample preparations. Therefore, we
compared HIF-1
 
 
 
 mRNA quantities in the oxidative
soleus muscle with gastrocnemius and quadriceps gly-
colytic muscles by semi-quantitative RT-PCR, since no
mRNA variations were expected under such short-
term hypoxia. HIF-1
 
 
 
 mRNA expression was found to
be threefold higher in glycolytic muscles than in the
oxidative muscle (Fig. 1 B). The higher HIF-1
 
 
 
 pro-
tein quantity observed in glycolytic muscles was thus
found to be associated with a higher HIF-1
 
 
 
 mRNA
content.
 
CoCl
 
2
 
 Stress Induces an HIF-1
 
 
 
 Protein Increase but no 
mRNA Modiﬁcations in Differentiated C
 
2
 
C
 
12
 
 Muscle Cells
 
We wondered whether HIF-1
 
 
 
 regulation by hypoxia
would also involve mRNA regulation in skeletal muscle,
unlike other tissues. CoCl
 
2
 
 is known to mimic acute
hypoxia upon in vitro HIF-1 activity induction (Wang et
al., 1995). It inhibits HIF-1
 
 
 
 ubiquitination and conse-
quently its degradation by the proteasome, thus allow-
ing formation of the active HIF-1
 
 
 
/HIF-1
 
 
 
 complex.
Myotube-differentiated C
 
2
 
C
 
12
 
 cells were stressed for 3 h
with 200 
 
 
 
M CoCl
 
2
 
 treatments. As expected (Wang et
al., 1995), Western blot analysis revealed an increase in
HIF-1
 
 
 
 protein (Fig. 2 A), but no variations in mRNA
contents were detected by semiquantitative RT-PCR
(Fig. 2, B and C). This was in agreement with the hy-
pothesis that the increase in HIF-1
 
 
 
 protein was only
due to a decrease in HIF-1
 
 
 
 degradation, as very well
documented in other tissues (Wenger, 2000).
 
Variations in HIF-1a mRNA in a Model of Muscle Energy 
Metabolism Switch
 
To further test the hypothesis that the HIF-1
 
 
 
 protein
level differences reported above between oxidative and
glycolytic muscles was due to constitutive differences in
HIF-1
 
 
 
 mRNA quantities between the two kinds of mus-
cles and not to artifactual hypoxic conditions, we ana-
lyzed another physiological situation. Instead of com-
paring different muscles, we used a procedure that in-
duced an energy metabolism switch within the same
muscle. Thus, HIF-1
 
 
 
 mRNA expression was analyzed
by semiquantitative RT-PCR in rat soleus and gastrocne-
mius muscles submitted to 2 wk of activity restriction by
hindlimb suspension (Diffee et al., 1991). The anti-
gravity oxidative soleus muscles were 
 
 
 
40% atrophied,
and 
 
 
 
20% of the oxidative ﬁbers were replaced by gly-
colytic ﬁbers, as assessed via the myosin isoform contents
that were studied in one of our previous works (Cros et
al., 1999). In this situation of oxidative to glycolytic en-
ergy metabolism transition within soleus muscle, HIF-
1
 
 
 
 mRNA was found to be threefold up-regulated (Fig.
3). Conversely, the glycolytic gastrocnemius muscles,
which underwent only 25% atrophy, showed no varia-
tion in energy metabolism (Jiang et al., 1992; Ohira et
Figure 2. HIF-1  expression
in differentiated C2C12 myo-
tubes treated with CoCl2.
HIF-1  expression was as-
sessed before treatment (T0)
and after 30 min (T30’) and
3 h (T 3h) in the presence of
200  M CoCl2. (A) Total cell
proteins were extracted and
analyzed by Western blotting
using anti–HIF-1  antibody.
An HIF-1 –speciﬁc 120-kD
band was detected, and an
80-kD nonspeciﬁc band
stained with amido-black is
shown as an even-lane loading
control. Lanes were evenly
loaded with 20  g of proteins.
(B) RNAs were prepared and
analyzed by semiquantitative
RT-PCR. Primers speciﬁc to
HIF-1  mRNA (for analysis) and to 18S rRNA (for normalization)
were used. Band intensities were measured in the linear ampliﬁca-
tion range, and the results are expressed as ratios between the
different time points and the T0-band intensities after normaliza-
tion by 18S rRNA variations. The results represent mean   SEM of
three independent experiments. 
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al., 1994), and the HIF-1  mRNA content was not sig-
niﬁcantly modiﬁed (Fig. 3).
DISCUSSION
Energy for muscle contraction is provided by oxidative
and glycolytic metabolisms. Skeletal muscles are made
of ﬁbers that differ according to the relative involve-
ment of each of these energy metabolisms. These me-
tabolism differences are associated with different me-
chanical properties that allow muscles to meet various
functional demands. As HIF-1 is a critical sensor of cel-
lular oxygen, we investigated expression of the regula-
tory HIF-1  subunit in accordance with the oxidative/
glycolytic energy balance in skeletal muscle. Variations
in this balance naturally occur in different muscles or
can be experimentally forced by modifying the me-
chanical constraints. In this hypoxia-free study, we have
shown (a) higher HIF-1  expression in predominantly
glycolytic muscles than in the predominantly oxidative
soleus muscle, and (b) an HIF-1  expression increase
in the oxidative to glycolytic energy transition, which
occurs in soleus muscle activity reduction imposed by
hindlimb suspension as shown in different previous
works including ours (Diffee et al., 1991; Ohira et al.,
1992; Cros et al., 2001). These HIF-1  variations were
noted at the protein level but also at the mRNA level.
The existence of HIF-1  mRNA variations ruled out the
possibility of simple hypoxia artifacts in RNA prepara-
tions from glycolytic muscles. Indeed, as conﬁrmed in
the present work by the experimental CoCl2 treatment
of C2C12 myoblasts, muscle cells react like other cells by
regulating HIF-1  protein and not HIF-1  mRNA.
It was not surprising to detect HIF-1  expression in
normoxic skeletal muscle. Indeed, contrary to most tis-
sues, it has been shown that HIF-1  is present under
normoxic conditions in a few mouse tissues, including
brain and skeletal muscle, where its level increases in
response to systemic hypoxia (Stroka et al., 2001) or is-
chaemia (Milkiewicz et al., 2004). In the present work,
we conﬁrmed these observations, suggesting that HIF-1
could have a potential function in muscle oxygen ho-
meostasis under normoxia. Variations in HIF-1  con-
tent according to skeletal muscle ﬁber types in nor-
moxia conditions should be compared with the myo-
globin content. According to our results, oxidative
ﬁbers have a low HIF-1  content and are known to ex-
press a high level of myoglobin (Mb) (Lin et al., 2002),
which is responsible for their red color. Mb is a cy-
toplasmic hemoprotein able to link O2 in the intersti-
tial compartment to carry it inside the ﬁber (Brunori,
2001). Mb forms an intracellular oxygen reserve that to
a certain extent enables muscular ﬁbers to buffer varia-
tions in blood O2 supply (i.e., hypoxia) or to meet ﬁber
metabolism needs. In contrast, glycolytic ﬁbers were
shown here to have a high HIF-1  content but they ex-
press a low level of Mb (Vogt et al., 2001). In this case,
the Mb level is not efﬁcient enough to compensate for
alterations in O2 homeostasis (i.e., hypoxia), and the
higher HIF-1  content in glycolytic ﬁbers would be
necessary to provide satisfactory hypoxia protection for
these ﬁbers. Moreover, a balance between HIF-1  and
Mb was recently documented in a study of Mb / 
knocked-out mice (Grange et al., 2001). Indeed, these
mice were viable and showed signiﬁcant phenotypic
modiﬁcations to compensate for the Mb absence, in-
cluding HIF-1  up-regulation and metabolism transi-
tions from oxidative to glycolytic muscle ﬁbers (Grange
et al., 2001). Conversely, a recent study of HIF-1  / 
knocked-out mice showed no variation in ﬁber type
composition in soleus and gastrocnemius muscles (Ma-
son et al., 2004). However, a clear shift from glycolytic
to oxidative muscle metabolism was detected during
exercise of these modiﬁed mice in comparison to wild-
type mice. Taken together, these points could be ex-
plained by the presence of an O2 regulation system
based mainly on Mb in oxidative ﬁbers and on an HIF-1
complex in glycolytic ﬁbers.
Finally, it also should be considered than HIF-1 has a
wider role than oxygen sensing. Its expression higher
in normoxic glycolytic muscles than in oxidative mus-
Figure 3. Comparison of HIF-1  mRNA expression in soleus and
gastrocnemius muscles atrophied by unloading versus control
muscles. Total RNAs isolated from rat muscle pools were analyzed
by semiquantitative RT-PCR. HIF-1  mRNAs were ampliﬁed for
analysis and 18S rRNAs were ampliﬁed for normalization. Band
intensity was measured in the linear ampliﬁcation range, and the
results are expressed in an arbitrary unit after normalization by
18S rRNA variations. Histograms represent mean   SEM of three
independent RT-PCR experiments from two independent RNA
preparations. *, signiﬁcantly different from control (soleus muscle,
P   0.007).Pisani and Dechesne 177
cles may also be related to other HIF-1 functions. HIF-1
is involved in many cellular pathways, such as glucose
uptake and carbohydrate metabolism. For instance,
HIF-1 activated genes include hexokinase 1 and 2, eno-
lase 1, lactate dehydrogenase A, pyruvate kinase, etc.
(Semenza, 2001). The proteins encoded by these genes
play key roles in energy metabolism. They act at impor-
tant steps of energy supply process, especially for the
anaerobic metabolism of muscle glycolytic ﬁbers. In
these ﬁbers, an important pathway required for ATP
production is the degradation of endogenous glycogen
through the glycolytic pathway to pyruvate and/or lac-
tic acid. HIF-1 also activates glucose transporter 1, one
of the glucose transporter isoforms expressed in skele-
tal muscle (Booth and Baldwin, 1996; Semenza, 2001).
This is of special interest since the rate-limiting step for
glucose use by muscle is the glucose transport. Alto-
gether, these considerations make very conceivable that
higher content of the transcription factor HIF-1 in gly-
colytic muscles actively contributes to the adequate ex-
pression of several genes involved in the energy glyco-
lytic supply.
In conclusion, this work conﬁrms differences in the
HIF-1–mediated cellular pathway regulations between
normoxic oxidative and glycolytic skeletal muscle ﬁ-
bers. The higher HIF-1  expression observed under
the lower O2 supply conditions in glycolytic ﬁbers un-
derlines the importance of HIF-1 for maintaining mus-
cle homeostasis and HIF-1 involvement in muscle plas-
ticity to tailor the metabolism, and therefore the me-
chanical properties, to meet the functional demand.
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